Evidence Hub

Hematoma-driven immuno-epigenetic remodeling after intracerebral hemorrhage: cell-type-specific mechanisms and therapeutic opportunities

Li Y, Jiang W, Zhong F, Dong M

Frontiers in immunology, 2026

Abstract

Intracerebral hemorrhage (ICH) is a life-threatening subtype of stroke characterized by the acute accumulation of blood within the brain parenchyma and progressive secondary brain injury. After ICH, dysregulated neuroinflammation drives a cascade of secondary injury processes that shape neurological deterioration and long-term recovery. However, the molecular mechanisms that determine the magnitude, temporal evolution, and resolution of immune-inflammatory responses after ICH remain incompletely understood, limiting the development of targeted therapeutic strategies. Accumulating evidence indicates that epigenetic regulation constitutes a critical layer controlling neuroinflammatory programs after ICH. Hematoma-derived stimuli, including hemoglobin degradation products, iron overload, oxidative stress, and damage-associated molecular patterns, create a unique inflammatory microenvironment that reshapes gene-regulatory landscapes in resident and infiltrating cells. DNA methylation remodeling, histone modification dynamics, chromatin accessibility alterations, and non-coding RNA regulatory networks collectively orchestrate cell-type-specific transcriptional reprogramming in microglia, astrocytes, endothelial cells, neurons, and infiltrating leukocytes. Rather than serving as passive consequences of tissue injury, these epigenetic processes actively modulate innate immune activation, cytokine production, leukocyte recruitment, blood-brain barrier integrity, and the balance…

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free